Bipolar disorder included in NICE work programme

October 27, 2003

NHS professionals are to be given new clinical guidelines in two important areas of mental health as part of NICE's …

‘Bogus disease’ argument flares up again

October 27, 2003

The British Medical Journal has accused the pharmaceutical industry of creating bogus disease areas in order to sell treatments.The respected …

Exanta promise for AstraZeneca

October 27, 2003

AstraZeneca's new anticoagulant Exanta has shown to be more effective than warfarin in preventing stroke in patients suffering from arrhythmia.Exanta …

NICE to review statins

October 27, 2003

Little price competition in UK, says report

October 27, 2003

Price competition is not a major factor in the UK prescription pharma market, according to a Department of Health report.The …

PFI hospitals failing, say unions

October 27, 2003

Hospitals built under the private finance initiative are suffering from financial problems, bed shortages and poor design, according to a …

Patent challenge to Galen’s new product

October 27, 2003

Galen faces a legal challenge in the US over the patent rights to a product it bought only last month.The …

OTC Claritin hits Schering-Plough

October 27, 2003

Schering-Plough has admitted that it underestimated the effect that Claritin switching to an over-the-counter product would have on its profits.The …

Labour split over foundation trusts exposed

October 27, 2003

Deep divisions within the Labour party over foundation hospitals have been further exposed in the House of Commons.More than 100 …

AstraZeneca picks Publicis and WPP as advertising partners

October 27, 2003

AstraZeneca will work exclusively with Publicis and WPP agencies in the US following a rationalisation of its advertising partnerships.The review, …

Pension fund urges GSK to act on AIDS

October 27, 2003

The world's largest pension fund has urged GlaxoSmithKline to step up its efforts to help combat the AIDS pandemic in …

Long-awaited diabetes NSF launched

October 27, 2003

The long awaited diabetes national service framework has been launched with demanding new targets for the improvement of NHS services.By …

Investment banker to be Elan chief executive

October 27, 2003
Elan

Kelly Martin, a former senior executive at Merrill Lynch, has been named chief executive of troubled Irish pharmaceutical company Elan.The …

Industry’s legal challenge to ‘arbitrary’ pricing

October 27, 2003

European industry body EFPIA is seeking legal action against the Italian Government new reimbursement and pricing policy, which it believes …

The Gateway to Local Adoption Series

Latest content